Cisplatin nephrotoxicity is mediated by deoxyribonuclease I

Alexei G Basnakian1, Eugene O Apostolov, Xiaoyan Yin

  • 1University of Arkansas for Medical Sciences, Department of Internal Medicine, Division of Nephrology, 4301 W. Markham Street #501, Little Rock, AR 72205, USA. basnakianalexeig@uams.edu

Insights

Deoxyribonuclease I (DNase I) plays a key role in cisplatin-induced kidney damage. DNase I knockout mice show significant protection against this chemotherapy-related nephrotoxicity.

Area of Science:

  • Nephrology
  • Oncology
  • Molecular Biology

Background:

  • Cisplatin is a vital chemotherapy drug, but its use is restricted by kidney toxicity (nephrotoxicity).
  • The precise mechanism of cisplatin-induced nephrotoxicity remains unclear but involves DNA fragmentation by an unknown endonuclease.
  • Deoxyribonuclease I (DNase I) is a known active renal endonuclease, and its inhibition protects kidney cells in vitro.

Purpose of the Study:

  • To investigate the specific role of deoxyribonuclease I (DNase I) in cisplatin-induced nephrotoxicity.
  • To determine if DNase I is the endonuclease responsible for cisplatin-induced kidney damage.

Main Methods:

  • Utilized deoxyribonuclease I (DNase I) knockout (KO) mice and primary renal tubular epithelial cells from these mice.
  • Assessed cisplatin toxicity in vitro using cultured renal tubular epithelial cells.
  • Evaluated cisplatin-induced nephrotoxicity in vivo using functional (blood urea nitrogen, serum creatinine) and histological (tubular necrosis, DNA fragmentation) markers in DNase I KO mice.

Main Results:

  • DNase I accounts for approximately 80% of renal endonuclease activity.
  • Renal tubular epithelial cells from DNase I KO mice were resistant to cisplatin injury in vitro.
  • DNase I KO mice exhibited significant protection against cisplatin-induced nephrotoxicity, with improved functional and histological outcomes.

Conclusions:

  • Deoxyribonuclease I (DNase I) is essential for the development of cisplatin-induced nephrotoxicity.
  • Targeting DNase I may offer a protective strategy against chemotherapy-induced kidney damage.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...